DE69705110D1 - Topische pharmazeutische zusammensetzungen, welche heparin enthalten - Google Patents

Topische pharmazeutische zusammensetzungen, welche heparin enthalten

Info

Publication number
DE69705110D1
DE69705110D1 DE69705110T DE69705110T DE69705110D1 DE 69705110 D1 DE69705110 D1 DE 69705110D1 DE 69705110 T DE69705110 T DE 69705110T DE 69705110 T DE69705110 T DE 69705110T DE 69705110 D1 DE69705110 D1 DE 69705110D1
Authority
DE
Germany
Prior art keywords
thrombosis
topical pharmaceutical
hematoma
pharmaceutical compositions
containing heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69705110T
Other languages
English (en)
Other versions
DE69705110T2 (de
Inventor
Rajko D Medenica
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHAKER, GHASSAN I., LONDON, GB
Original Assignee
SHAKER GHASSAN I
MEDENICA SMILJA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHAKER GHASSAN I, MEDENICA SMILJA filed Critical SHAKER GHASSAN I
Application granted granted Critical
Publication of DE69705110D1 publication Critical patent/DE69705110D1/de
Publication of DE69705110T2 publication Critical patent/DE69705110T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
DE69705110T 1996-02-22 1997-02-18 Topische pharmazeutische zusammensetzungen, welche heparin enthalten Expired - Fee Related DE69705110T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/603,861 US5668119A (en) 1996-02-22 1996-02-22 Topical pharmaceutical containing heparin and method of treatment
PCT/US1997/002405 WO1997030714A2 (en) 1996-02-22 1997-02-18 Topical pharmaceutical composition containing heparin

Publications (2)

Publication Number Publication Date
DE69705110D1 true DE69705110D1 (de) 2001-07-12
DE69705110T2 DE69705110T2 (de) 2002-01-31

Family

ID=24417231

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69705110T Expired - Fee Related DE69705110T2 (de) 1996-02-22 1997-02-18 Topische pharmazeutische zusammensetzungen, welche heparin enthalten

Country Status (7)

Country Link
US (1) US5668119A (de)
EP (1) EP0881904B1 (de)
AT (1) ATE201823T1 (de)
AU (1) AU709142B2 (de)
CA (1) CA2247198C (de)
DE (1) DE69705110T2 (de)
WO (1) WO1997030714A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
AP2006003831A0 (en) * 2004-01-20 2006-12-31 Panacea Biotec Ltd Compositions comprising glycosaminoglycan and nonsteroidal anti-inflamatory drug
JP2010280609A (ja) * 2009-06-04 2010-12-16 Amato Pharmaceutical Products Ltd 肩こり、腰痛、筋肉痛、打撲、捻挫、頸肩腕症候群及び外傷による内出血の治療剤
IT1400232B1 (it) 2010-05-07 2013-05-24 Advance Holdings Ltd Composizione farmaceutica topica comprendente eparina
BR112012031906A2 (pt) 2010-06-17 2016-08-23 Momenta Pharmaceuticals Inc métodos e composições para modular o crescimento de cabelo e pelos.
WO2014109417A1 (ko) * 2013-01-08 2014-07-17 (주)노바셀테크놀로지 콜라겐 합성능이 있는 신규 펩타이드 및 그의 용도
US9078853B2 (en) 2013-06-18 2015-07-14 Cmpd Licensing, Llc Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
US9999604B2 (en) 2016-11-17 2018-06-19 Cmpd Licensing, Llc Compounded solutions of diclofenac and lidocaine and methods
US11737975B2 (en) 2016-11-17 2023-08-29 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US10525025B2 (en) 2016-11-17 2020-01-07 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US10966946B2 (en) 2016-11-17 2021-04-06 Cmpd Licensing, Llc Compounded compositions and methods for treating pain

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB891554A (en) * 1959-10-19 1962-03-14 Applic Chimiques D Etudes Et D Galenic suppository containing salts of heparin
FR1730M (fr) * 1962-01-17 1963-03-18 Charles Riviere Nouvelle composition de collyre.
FR2035765A1 (en) * 1969-03-06 1970-12-24 Inst Rech Scient Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates
CH512246A (fr) * 1970-03-05 1971-09-15 Inst De Cercetari Chimico Farm Procédé de préparation d'un héparinate d'antibiotique à action anticoagulante, antibactérienne prolongée pour application topique
DE2806515C2 (de) * 1978-02-16 1983-08-11 Gödecke AG, 1000 Berlin Amorphes Heparin-Natrium und Verfahren zu dessen Herstellung
DE3020220A1 (de) * 1980-05-28 1981-12-03 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des heparin, der heparinoide, ihre herstellung und sie enthaltende arzneimittel
DE3049445A1 (de) * 1980-12-30 1982-07-29 Theodor Prof. Dr. 4400 Münster Eckert "organische salze des heparin, der heparinoide, ihre herstellung und sie enthaltende arzneimittel"
SU1080824A1 (ru) * 1982-12-28 1984-03-23 Центральный научно-исследовательский кожно-венерологический институт Способ лечени первичного серопозитивного и вторичного свежего сифилиса
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
US4983580A (en) * 1986-04-04 1991-01-08 Allergan, Inc. Methods and materials for use in corneal wound healing
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5272135A (en) * 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides

Also Published As

Publication number Publication date
AU2190097A (en) 1997-09-10
WO1997030714A3 (en) 1997-10-16
EP0881904A2 (de) 1998-12-09
EP0881904B1 (de) 2001-06-06
AU709142B2 (en) 1999-08-19
ATE201823T1 (de) 2001-06-15
CA2247198C (en) 2006-08-29
US5668119A (en) 1997-09-16
DE69705110T2 (de) 2002-01-31
CA2247198A1 (en) 1997-08-28
WO1997030714A2 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
ES2137372T3 (es) Solucion antifungica para las uñas.
ATE269066T1 (de) Kombinationstherapie zur prophylaxe und/oder behandlung von gutartiger prostatischer hyperplasie
SE9404196D0 (sv) New antithrombotic formulation
DE69725293D1 (de) N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
DE69705110T2 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
DE69710065T2 (de) Androsten-derivate
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
DE69333413D1 (de) 5-ht2-antagonisten in der behandlung venöser zustände
RU95112534A (ru) Дерматансульфаты и их соли, противотромбозные средства, способ предупреждения или лечения тромбозов, способ предупреждения или лечения синдрома рассеянной интраваскулярной коагуляции, способ лечения инфаркта миокарда
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
ES2140575T3 (es) L-lisil-glicil-l-histidina y agente terapeutico para curar heridas que lo contiene.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
DK227090A (da) Organisk guldkompleks til topisk anvendelse
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
DE69230644T2 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
ES2139729T3 (es) Uso del factor xiii aplicado topicamente para la inhibicion de hemorragias.
DE69433923D1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
BR9608721A (pt) Composição farmacêutica, e, processo para tratar inflamação
SE8802040D0 (sv) New use
ATE147983T1 (de) Transdermales therapeutisches system mit pentylentetrazol als wirkstoff

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SHAKER, GHASSAN I., LONDON, GB

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee